Gara Jalqabaatti › COPD › New York
Qorannoo klinikaalii COPD New York keessatti
Qorannoo 20 COPD f New York keessatti hirmaatuu jiru.
Magaalota New York keessatti
Takkalaa qorannoo (Ingiliffa)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Mount Kisco
- GSK Investigational Site, New Windsor
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, North Massapequa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Albany
- Research Site, Massapequa
- Research Site, New Windsor
- fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Trinity Medical, WNY- Site Number : 8400157, Buffalo
- Mid Hudson Medical Research - New Windsor- Site Number : 8400004, New Windsor
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- New York Hospital Queens- Site Number : 8400058, Flushing
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Mount Kisco
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Mount Sinai, Icahn School of Medicine, New York
- Columbia University, New York
- Cornell University, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Buffalo
- Research Site, Cortland
- Research Site, Horseheads
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Staten Island
- Research Site, Syracuse
- Research Site, The Bronx
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Northwell Health Physician Partners at Chappaqua, Chappaqua
- New York Presbyterian Queens, Flushing
- Northern Westchester Hospital, Mount Kisco
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 35 hanga 80 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07363694A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Equity Medical LLC, New York
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06944925Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Icahn School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jira
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Columbia University, New York
- Weill Cornell Medical Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 30 hanga 55 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05033990Evaluation Of The Lung Microbiome In NTM Bronchiectasis
- New York University School of Medicine, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT02779478Lung Microbiome and Inflammation in Early COPD
- New York University School of Medicine, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT02777879PiMZ Longitudinal Cohort (PiMZ Logic)
- Columbia University Irving Medical Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ama-2026 · NCT06505603Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
- Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT01776398Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
- Ichan School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jira
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 06-Onk-2025 · NCT06634810Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Our Lady of Lourdes Hospital, Binghamton
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 05-Hag-2025 · NCT06122077PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- Mount Sinai, New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Onk-2023 · NCT05306743Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.